Krystal Biotech Inc (KRYS NASDAQ) stock market data APIs
$235.4537
4.19(1.8%)
as of December 18, 2025
Try our APIs with
free plan!
Krystal Biotech Inc Financial Data Overview
Price chart is built with
Anychart
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Prev. Close
235.4537
Open
239.6416
High
241.1803
Low
229.6019
52 wk Range
122.8-248.595
Market Cap
6 767 M
P/E Ratio
34.9356
Shares Outstanding
28 998 K
Revenue
373 M
EPS
2.66
Beta
0.483
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Krystal Biotech Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Krystal Biotech Inc data using free add-ons & libraries
Get Krystal Biotech Inc Fundamental Data
Krystal Biotech Inc Fundamental data includes:
- Net Revenue: 373 M
- EBITDA: 160 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-03
- EPS/Forecast: 1.09
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Krystal Biotech Inc News
New
Why a Fund Placed a $13 Million Bet on Ambarella Stock Before a 20% Post-Earnings Drop
Key Points New York City-based S Squared Capital increased its Ambarella holding by 35,000 shares in the third quarter. The overall value of the position increased by about $4.8 million. As of quarte...
Why a Fund Placed a $13 Million Bet on Ambarella Stock Before a 20% Post-Earnings Drop
Key Points New York City-based S Squared Capital increased its Ambarella holding by 35,000 shares in the third quarter. The overall value of the position increased by about $4.8 million. As of quarte...
Is IPG Photonics Stock a Buy as One Fund Builds a $9 Million Stake in the Firm?
Key Points New York City-based S Squared Technology increased its position in IPG Photonics Corporation by 45,050 shares in the third quarter. The overall value of the position rose by about $4.4 mil...
Why One Fund Has an $8.5 Million Bet on Five9 Despite a 50% One-Year Stock Collapse
Key Points New York City-based S Squared Technology added 165,000 shares of Five9 in the third quarter. As of quarter-end, the fund reported holding 350,000 FIVN shares valued at $8.5 million. Five9 ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
